Antibodies in Scleroderma: Direct Pathogenicity and Phenotypic Associations

Overview

Journal Curr Rheumatol Rep

Publisher Current Science

Specialty Rheumatology

Date 2004 Mar 16

PMID 15016347

Citations 23

Authors

Lorinda Chung

Paul J Utz

Affiliations

Soon will be listed here.

Abstract

Scleroderma is an autoimmune disease involving endothelial cell damage and fibroblast overproduction of extracellular matrix. Several autoantibodies present in the sera of patients with scleroderma, including anti-endothelial cell, antifibroblast, anti-matrix metalloproteinase, and antifibrillin-1 antibodies, may directly contribute to disease pathogenesis. Scleroderma also is characterized by the presence of antinuclear and antinucleolar antibodies, which correlate with particular phenotypes. These include antitopoisomerase-I, anticentromere, antihistone, anti-polymyositis/scleroderma, anti-Th/To, anti-U3-small nucleolar ribonucleoprotein particle, anti-U1-small nuclear ribonucleoprotein particle, anti-RNA polymerase, and anti-B23 antibodies. Other antibodies classically associated with other autoimmune diseases, such as antiphospholipid, antineutrophil cytoplasmic, and antimitochondrial antibodies, also have been described in patients with scleroderma. This review will summarize the various autoantibodies associated with scleroderma, their putative pathogenic roles, and their phenotypic correlations.

Citing Articles

A comparative study of different antiviral treatment protocols in HCV related cryoglobulinemic vasculitis.

Allam W, Hegazy M, Hussein M, Zoheir N, Quartuccio L, El-Khamisy S Sci Rep. 2024; 14(1):11840.

PMID: 38782988 PMC: 11116471. DOI: 10.1038/s41598-024-60490-z.

Extracellular matrix stiffness-The central cue for skin fibrosis.

Wang K, Wen D, Xu X, Zhao R, Jiang F, Yuan S Front Mol Biosci. 2023; 10:1132353.

PMID: 36968277 PMC: 10031116. DOI: 10.3389/fmolb.2023.1132353.

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation.

Ayoglu B, Donato M, Furst D, Crofford L, Goldmuntz E, Keyes-Elstein L Ann Rheum Dis. 2023; 82(5):670-680.

PMID: 36653124 PMC: 10176357. DOI: 10.1136/ard-2021-221926.

Heart disease in the course of systemic sclerosis - an observational study.

Nowakowska-Plaza A, Wronski J, Weronska-Tatara J, Forys A, Kraska A, Wislowska M Reumatologia. 2022; 60(5):318-325.

PMID: 36381205 PMC: 9661404. DOI: 10.5114/reum.2022.120755.

Serum IgG Profiling of Toddlers Reveals a Subgroup with Elevated Seropositive Antibodies to Viruses Correlating with Increased Vaccine and Autoantigen Responses.

Pichilingue-Reto P, Raj P, Li Q, Dozmorov I, Karp D, Wakeland E J Clin Immunol. 2021; 41(5):1031-1047.

PMID: 33656624 PMC: 7927113. DOI: 10.1007/s10875-021-00993-w.

References

Mitri G, Lucas M, Fertig N, Steen V, Medsger Jr T . A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum. 2003; 48(1):203-9. DOI: 10.1002/art.10760. View

Kuwana M, Kimura K, Hirakata M, Kawakami Y, Ikeda Y . Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases. Ann Rheum Dis. 2002; 61(9):842-6. PMC: 1754228. DOI: 10.1136/ard.61.9.842. View

Endo H, Hosono T, Kondo H . Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol. 1994; 21(5):864-70. View

Khanna D, Aggarwal A, Bhakuni D, Dayal R, Misra R . Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis. J Rheumatol. 2003; 30(6):1248-52. View

Ulanet D, Wigley F, Gelber A, Rosen A . Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension. Arthritis Rheum. 2003; 49(1):85-92. DOI: 10.1002/art.10914. View

Schoenroth L, Fritzler M, Lonzetti L, Senecal J . Antibodies to beta2 glycoprotein I and cardiolipin in SSc. Ann Rheum Dis. 2002; 61(2):183-4. PMC: 1753982. DOI: 10.1136/ard.61.2.183-a. View

Chizzolini C, Raschi E, Rezzonico R, Testoni C, Mallone R, Gabrielli A . Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum. 2002; 46(6):1602-13. DOI: 10.1002/art.10361. View

Harris M, Rosen A . Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies. Curr Opin Rheumatol. 2003; 15(6):778-84. DOI: 10.1097/00002281-200311000-00016. View

Sato S, Hasegawa M, Fujimoto M, Tedder T, Takehara K . Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol. 2000; 165(11):6635-43. DOI: 10.4049/jimmunol.165.11.6635. View

10.

Antonioli C, Danieli E, Airo P, Cattaneo R, Tincani A . More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis. Ann Rheum Dis. 2003; 62(6):589-90. PMC: 1754560. DOI: 10.1136/ard.62.6.589. View

11.

Okano Y, Medsger Jr T . Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis. Arthritis Rheum. 1990; 33(12):1822-8. DOI: 10.1002/art.1780331210. View

12.

Brouwer R, Pruijn G, van Venrooij W . The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma. Arthritis Res. 2001; 3(2):102-6. PMC: 128886. DOI: 10.1186/ar147. View

13.

Reveille J, Solomon D . Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum. 2003; 49(3):399-412. DOI: 10.1002/art.11113. View

14.

Miyata N, Kobayashi T, Matsukawa Y, Sawada S, Nishinarita S, Horie T . [Anti-neutrophil cytoplasmic autoantibody-associated rapid progressive glomerulonephritis complicated with both limited and diffuse scleroderma]. Nihon Rinsho Meneki Gakkai Kaishi. 2003; 25(6):473-9. DOI: 10.2177/jsci.25.473. View

15.

Arnett F, Reveille J, Goldstein R, Pollard K, Leaird K, Smith E . Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum. 1996; 39(7):1151-60. DOI: 10.1002/art.1780390712. View

16.

Whyte J, Hough D, Maddison P, McHugh N . The association of primary biliary cirrhosis and systemic sclerosis is not accounted for by cross reactivity between mitochondrial and centromere antigens. J Autoimmun. 1994; 7(3):413-24. DOI: 10.1006/jaut.1994.1030. View

17.

Hu P, Fertig N, Medsger Jr T, Wright T . Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum. 2003; 48(5):1363-73. DOI: 10.1002/art.10977. View

18.

Brouwer R, Vree Egberts W, Hengstman G, Raijmakers R, van Engelen B, Seelig H . Autoantibodies directed to novel components of the PM/Scl complex, the human exosome. Arthritis Res. 2002; 4(2):134-8. PMC: 83843. DOI: 10.1186/ar389. View

19.

Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I . Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med. 2003; 349(2):139-45. DOI: 10.1056/NEJMoa022328. View

20.

Zhou X, Tan F, Xiong M, Milewicz D, Feghali C, Fritzler M . Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. J Immunol. 2001; 167(12):7126-33. DOI: 10.4049/jimmunol.167.12.7126. View